Email or username:

Password:

Forgot your password?
Top-level
CurrentBias

Here's the thing, though. This will never work for all, if not most of the aerosols you inhale that travel directly, deep into the lungs. Some will hit the nasal mucosa and bind to the iota-carageenan, and this may reduce the overall viral load, but it's not going to stop a cloud of SARSCoV2. Only a respirator can do that

3 comments
Paul Sochacki

@currentbias That's a good point - I wonder how effective a nasal spray would be for people constantly dining out or partying like it's 2019. I imagine people breathing through their mouths while eating, drinking, and socializing would defeat the purpose of a nasal spray, too.

ixtility

@BioGeek23 @currentbias Agree. Have no relevant specialist background, but have never thought nasal sprays alone would be a good defense because some inhaled air will bypass sprayed areas. Also, am aware nasal sprays may have risks. Micro-organisms can reach the brain (e.g. causing meningitis) from the nose and throat. Maybe paranoid, but people losing eyes/sight from contaminated eye drops makes me wary about using nasal sprays. Respirator = physical barrier = better IMHO

A Concerned Scientist

@currentbias

I really don't know how well this paper has held up over the years, but it's something I've gone back to a few times since even before COVID as a reference.

ncbi.nlm.nih.gov/pmc/articles/

Someone will probably come and tell me it's horribly outdated now :)

"Inhaled droplets of more than 10 μm in diameter are trapped in the turbinates of the nose (Fig. 2), whereas those measuring 5–10 μm often reach the trachea and bronchioles. Many of these particles become trapped in the layer of mucus that blankets the ciliated epithelium and are carried by ciliary action to the pharynx, where they are swallowed or coughed out. Smaller particles still can be inhaled directly into the lung and some may reach the alveoli. Here, virus may be phagocytosed and destroyed by alveolar macrophages (although some viral species undergo an abortive cycle of replication and others have developed the capacity to replicate in macrophages). A few virions will succeed in attaching to susceptible epithelial cells via the appropriate ligand–receptor pairing and thereby initiate infection. Progeny virions will be released a few hours later, often by budding from the apical surface of the cell into the lumen of the respiratory tract, and then initiate a second cycle of infection in adjacent or more distant cells.

...

While some viruses have a predilection for one particular part of the respiratory tract, most are capable of causing disease at any level..."

@currentbias

I really don't know how well this paper has held up over the years, but it's something I've gone back to a few times since even before COVID as a reference.

ncbi.nlm.nih.gov/pmc/articles/

Someone will probably come and tell me it's horribly outdated now :)

"Inhaled droplets of more than 10 μm in diameter are trapped in the turbinates of the nose (Fig. 2), whereas those measuring 5–10 μm often reach the trachea and bronchioles. Many of these particles become trapped...

Go Up